News

Evestra Snags DoD Grant For Experimental Breast Cancer Drug Research

By David Holley, Xconomy San Antonio—A small Texas biotech that develops women’s health ...

Promising Treatment for Ebola Virus to be Tested at Texas Biomed

Ricardo Carrion, Jr., Ph.D. During the West African Ebola outbreak that began in 2013, an experimental ...

News
San Antonio’s Mission Pharmacal rolls out two new products
November 19, 2015

By Peggy O'Hare on November 19, 2015 at 3:27 PM

San Antonio pharmaceutical company Mission Pharmacal has introduced two new medications for adults suffering from coughs and colds.

The company has nationally launched HycofenixT Oral Solution, a prescription medication that relieves three cough and cold symptoms. The product features the first and only combination of hydrocodone, pseudoephedrine and guaifenesin approved by the U.S. Food and Drug Administration.

Hycofenix relieves coughing, loosens respiratory secretions for a more productive cough and clears nasal congestion.

Mission Pharmacal also launched another new product, FlowtussT Oral Solution, a prescription that relieves coughing and loosens respiratory secretions. The medication is an option for patients who are coughing, but do not need a nasal decongestant. It contains hydrocodone bitartrate and guaifenesin.

Both medications come in a black raspberry flavor and have been approved by the FDA for patients 18 years old and older.

To support customer needs related to Hycofenix and Flowtuss, we have nearly doubled the size of our sales team, said John McLaughlin, sales director of Mission Pharmacal’s primary care division. We are excited that the addition of these products in a new therapeutic class enables us to grow and better serve primary care providers and their patients.

Stay informed. Subscribe to BioMed SA news alerts.